
March 19, 2023
Hygrovest Limited (ASX: HGV) ("HGV" or the “Company”) is an Australian-listed specialist investment company, which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and other financial assets.
Review of HGV Board Composition
The HGV Board has reviewed the composition of its Board to ensure the continued growth of the Company and continued diversification of its portfolio of investments. Based on that review, it is pleased to announce that two new Directors will be joining the HGV Board as part of an ongoing process of Board renewal.
Consequently, HGV announces the following changes to the composition of its Directors.
New Appointments
The HGV Board has appointed Messrs Warwick Sauer and David Prescott as Independent Non-Executive Directors, effective immediately.
Warwick Sauer will also become a member of the Audit and Risk Committee.
Profiles for each of Messrs Warwick Sauer and David Prescott are attached to this announcement.
Retirements
Both Messrs Winton Willesee and Michael Curtis will retire effective immediately.
Winton Willesee has served on the Company’s Board since 2014 and was a member of the Audit and Risk Committee.
Michael Curtis joined the Company’s Board in January 2019. Michael will remain in his role as Managing Partner of Parallax Ventures Inc. whose current term as HGV’s Investment Manager expires on 30 June 2023.
The remaining continuing Directors, Messrs Peter Wall and Doug Halley, have agreed to remain in place until such time that a new Investment Manager is appointed to HGV. At this time, one or both of Mr Wall and/or Mr Halley have indicated they also intend to resign from the HGV Board.
HGV’s Chairman, Mr Peter Wall noted, “I would like to personally acknowledge Winton and Michael for their considerable efforts and input over a long period and wish both of them well. I also welcome Warwick and David who collectively bring extensive experience in investment management, corporate governance and regulatory compliance to assist the Company build shareholder value.”
Click here for the full ASX Release
This article includes content from Hygrovest Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
HGV:AU
The Conversation (0)
12 January 2022
Hygrovest Limited
Building a globally diversified portfolio of companies in high-growth industries.
19 September
Cannabis Crossroads: Record US Demand Meets Federal Gridlock
The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
22 July
10 Biggest Cannabis Stocks in the US and Canada in 2025
After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
17 July
Cannabis Market Update: H1 2025 in Review
The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
25 June
Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout
Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
09 May
A State-by-State Guide to Cannabis in Australia
Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
01 May
New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025
Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00